Intrinsic Value of S&P & Nasdaq Contact Us

Flora Growth Corp. FLGC NASDAQ

NASDAQ Capital Marke • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score
47/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$173.50
+2127.2%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Flora Growth Corp. (FLGC) .

Criteria proven by this page:

  • VALUE (100/100, Pass) — analyst target implies upside (+2127.2%).
  • Analyst consensus target $173.50 (+2127.2% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 47/100 with 3/7 criteria passed.

SharesGrow 7-Criteria Score
47/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
FUTURE
73/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
MOAT
43/100
→ Income
GROWTH
73/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — FLGC

Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.00
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Analyst Target$173.50 (+2127.2%)

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2019 $-0.65 $0.00 $-2.84M -
2020 $-3.25 $106K $-14.26M -13451.9%
2021 $-6.52 $8.98M $-21.36M -237.9%
2022 $-13.73 $37.17M $-52.63M -141.6%
2023 $-7.33 $76.07M $-57.04M -75%
2024 $-1.30 $59.51M $-15.91M -26.7%
2025 $0.00 $14.5M $-4.43M -30.5%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message